Wellgistics Health (NASDAQ: WGRX) releases Q2 2025 quarterly results

Rhea-AI Filing Summary

Wellgistics Health, Inc. filed a current report to furnish a press release announcing its financial results for the second fiscal quarter ended June 30, 2025. The release, dated August 20, 2025, is attached as Exhibit 99.1 and is incorporated by reference into the disclosure items describing the results and related information.

The company specifies that the press release and related disclosures are being furnished, not filed, so they are not subject to certain liability provisions under the Securities Exchange Act and are not automatically incorporated into other securities law filings.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 08/22/2025 - 04:54 PM Learn about SEC filing dates

FAQ

What did Wellgistics Health (WGRX) disclose in this 8-K?

Wellgistics Health, Inc. furnished a press release announcing its financial results for the second fiscal quarter ended June 30, 2025, as Exhibit 99.1.

Which period’s results does Wellgistics Health (WGRX) discuss?

The company’s press release covers financial results for the second fiscal quarter ended June 30, 2025.

How did Wellgistics Health provide its Q2 2025 financial results?

The company issued a press release dated August 20, 2025, which is attached to the report as Exhibit 99.1 and incorporated by reference.

Are the Wellgistics Health Q2 2025 results considered filed with the SEC?

No. The company states that the press release and related information are furnished, not filed, and are not subject to certain Exchange Act Section 18 liabilities.

Which exhibit in the 8-K contains the Wellgistics Health Q2 2025 press release?

Exhibit 99.1 contains the press release announcing Wellgistics Health, Inc.’s second quarter 2025 financial results.

What other exhibit is included in the Wellgistics Health (WGRX) 8-K?

The filing also includes Exhibit 104, which is the cover page interactive data file embedded within the Inline XBRL document.

false 0002030763 0002030763 2025-08-20 2025-08-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 20, 2025

WELLGISTICS HEALTH, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-42530		93-3264234
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

3000 Bayport Drive

Suite 950

Tampa, FL 33607

(Address of principal executive officers) (Zip Code)

(844) 203-6092

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		WGRX		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

To the extent required, the information set forth under Item 7.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.02.

The information furnished under this Item 2.02, including the referenced exhibit, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by reference to such filing.

Item 7.01. Regulation FD Disclosure.

On August 20, 2025, the Company issued a press release announcing the Company’s financial results for the second fiscal quarter ended June 30, 2025. The press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

The press release shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such Section 18. The information in this Item 7.01, as well as Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Press Release by Wellgistics Health, Inc., dated August 20, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Wellgistics Health, Inc.
Dated: August 22, 2025	By:	/s/ Mark DiSiena
		Mark DiSiena
		Chief Financial Officer